Podcasts

Episode 60 | Exploring Lung Cancer Care and Research in New Zealand

In this episode, the focus is on the current state of lung cancer care and research in New Zealand.

Episode Summary

This episode of ‘Conversations in Lung Cancer Research’ hosted by Dr Alex Davis, features a discussion with Dr Laird Cameron and Dr Annie Wong on the current state of lung cancer care and research in New Zealand. The panel explores the challenges and disparities faced by thoracic cancer patients, particularly among the indigenous Māori population. The conversation highlights the differences between patient populations in New Zealand and Australia, the impact of rurality on cancer care, the importance of clinical trials and multinational collaborations, and the future prospects for lung cancer treatments and interventions.

Show Guests

  • Dr Alex Davis, Medical Oncologist, Northern Sydney Cancer Centre.
  • Dr Annie Wong, Consultant Medical Oncologist, Wellington Blood and Cancer Centre and Senior Lecturer, University of Otago Wellington and University of Auckland
  • Dr Laird Cameron, Medical Oncologist, Te Puriri o Te Ora, in Auckland and Senior Lecturer, University of Auckland. 
Lung cancer podcast- lung cancer care and research in New Zealand

Play Episode 60 | Exploring Lung Cancer Care and Research in New Zealand

More Podcasts

Host A/Prof Steven Kao is joined by A/Prof Venessa Chin and Dr Ben Kong,
Host A/Prof Mel Moore interviews Prof Zarnie Lwin OAM, University of Queensland; Medical Oncologist at Royal Brisbane and Women’s Hospital and The Prince Charles Hospital.
A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the critical and complex issue of smoking-related stigma in lung cancer.
Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.
Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.
Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.